Filter Results:
(65)
Show Results For
- All HBS Web
(123)
- News (51)
- Research (65)
- Multimedia (4)
- Faculty Publications (57)
Show Results For
- All HBS Web
(123)
- News (51)
- Research (65)
- Multimedia (4)
- Faculty Publications (57)
Sort by
- Article
Market-Based Solutions to Antitrust Threats—The Rejection of the Partners Settlement
By: Regina E. Herzlinger, Barak D. Richman and Kevin A. Schulman
Keywords: Health Care; Health Care Industry; Health Care Policy; Health Care Services; Antitrust; Health Care and Treatment; Health Industry; United States
Herzlinger, Regina E., Barak D. Richman, and Kevin A. Schulman. "Market-Based Solutions to Antitrust Threats—The Rejection of the Partners Settlement." New England Journal of Medicine 372, no. 14 (April 2, 2015): 1287–1289.
- August 2013 (Revised August 2014)
- Case
Aon Hewitt's Private Health Insurance Exchange
By: Regina E. Herzlinger, Aiden Y. Feng and Meghan D. Oliver
Aon Hewitt, a leading health insurance broker and consultant, is one of the first movers in forming exchanges to sell health insurance. What kinds of products should it offer on this exchange? View Details
- December 2010
- Article
HCAHPS and You: Using Experience-based Methodology to Deliver Exceptional Care Experiences and Outcomes
By: Regina E. Herzlinger, Anthony DiGioia III and Kevin J. Bozic
Herzlinger, Regina E., Anthony DiGioia III, and Kevin J. Bozic. "HCAHPS and You: Using Experience-based Methodology to Deliver Exceptional Care Experiences and Outcomes." Orthopedics Today (December 2010).
- October 2003 (Revised March 2008)
- Case
Salick Cardiovascular Centers: Business Plan
By: Regina E. Herzlinger, Kaushik Sen, Alex Tkachenko and Carolyn Wolff
A seasoned health services entrepreneur develops a business plan for a cardiovascular-focused factory. Will it work? View Details
Keywords: Factories, Labs, and Plants; Business Plan; Business Startups; Entrepreneurship; Medical Specialties; Health Industry
Herzlinger, Regina E., Kaushik Sen, Alex Tkachenko, and Carolyn Wolff. "Salick Cardiovascular Centers: Business Plan." Harvard Business School Case 304-007, October 2003. (Revised March 2008.)
- October 2002 (Revised June 2003)
- Background Note
New Frontiers in Target Discovery and Validation
By: Regina E. Herzlinger, Niv Caviar, Jon Chatterton and Andrea Lynn
Explains Immusol and Novartis's technology. View Details
Herzlinger, Regina E., Niv Caviar, Jon Chatterton, and Andrea Lynn. "New Frontiers in Target Discovery and Validation." Harvard Business School Background Note 303-054, October 2002. (Revised June 2003.)
- May 2015
- Case
Acıbadem Healthcare Group
By: Regina E. Herzlinger, Esel Çekin, Natalie Kindred and Gamze Yucaoglu
Acıbadem Healthcare Group is Turkey's only premium nationwide hospital network. This case focuses on Acıbadem’s potential expansion strategy after it was acquired by International Healthcare Holdings Berhad (IHH) in 2011, the world's second-largest publicly listed... View Details
Herzlinger, Regina E., Esel Çekin, Natalie Kindred, and Gamze Yucaoglu. "Acıbadem Healthcare Group." Harvard Business School Case 315-120, May 2015.
- Blog Post
Innovation in Health Care Education: A Call to Action
By: Regina E. Herzlinger, Vasant Kumar, Kevin Schulman and Karen Staman
Health care administration educators are at a crossroads: the health care sector is rife with inefficiencies, erratic quality, unequal access, and sky-high costs, complex problems which call for innovative solutions, and yet, according to our content analysis of top... View Details
Keywords: Health Care; Health Care Education; Education; Health; Health Care and Treatment; Health Industry; Education Industry
Herzlinger, Regina E., Vasant Kumar, Kevin Schulman, and Karen Staman. "Innovation in Health Care Education: A Call to Action." Health Affairs Blog (January 29, 2015). http://healthaffairs.org/blog/2015/01/29/innovation-in-health-care-education-a-call-to-action/.
- 01 Dec 2010
- Keynote Speech
Improving Health and Health Care: Who is Responsible? Who is Accountable?
By: Regina E. Herzlinger, Bruce Rosen, Avi Israeli and Steve Shortell
Keywords: Health
- 2015
- Other Teaching and Training Material
Innovating in Healthcare
By: Regina E. Herzlinger, Margo I. Seltzer and Kevin Schulman
With over 71,000 past enrollees, Innovating in Healthcare investigates the issues of health care spending, quality, and access that continue to plague America and global nations alike. With U.S. health care costs trending toward $4 trillion in 2020, the need to... View Details
Herzlinger, Regina E., Margo I. Seltzer, and Kevin Schulman. "Innovating in Healthcare." edX Inc., 2015. Video. (HarvardX Massive Open Online Course.)
- February 2021 (Revised June 2021)
- Case
Brainlab: Imaging a MedTech Future
By: Regina E. Herzlinger, Gregory P. Licholai and Federica Gabrieli
Can Brainlab, a privately held firm, compete with giants like Medtronic and Amazon in delivering the Digital Operating Room of the future? The CEO is pondering solutions for secure exchange of medical information, pricing a new robotic imaging device, and reorganizing... View Details
Keywords: Surgery; Robotics; Health Care; Private Healthcare; Pricing; Technology Platform; Acquisition; Business Growth and Maturation; Growth and Development Strategy; Business Strategy; Corporate Strategy; Corporate Entrepreneurship; Health Care and Treatment; Health; Innovation and Invention; Innovation and Management; Innovation Strategy; Technological Innovation; Applications and Software; Information Infrastructure; Information Technology; Digital Platforms; Health Industry; Europe; Germany; Munich
Herzlinger, Regina E., Gregory P. Licholai, and Federica Gabrieli. "Brainlab: Imaging a MedTech Future." Harvard Business School Case 321-087, February 2021. (Revised June 2021.)
- December 2009 (Revised September 2024)
- Case
Phreesia: The Patient Intake Company
By: Regina E. Herzlinger, Sunaina Yarlagadda and Brian L. Walker
How should the co-founders of an organization that provides patient sign-in and billing services scale their company after five years of successfully targeting small private physician practices? Phreesia had deployed a direct mail and sales force strategy that resulted... View Details
Herzlinger, Regina E., Sunaina Yarlagadda, and Brian L. Walker. "Phreesia: The Patient Intake Company." Harvard Business School Case 310-066, December 2009. (Revised September 2024.)
- June 2018
- Supplement
Amil and the Health Care System in Brazil (B)
By: Regina Herzlinger, Ana Maria Malik, Ruth Costas and Priscilla Zogbi
Brazilian Managed Care Organization Amil faces a series of challenges while trying to redefine the terms of its relationship with hospitals and clinics and to implement a new health care model based on primary care and family medicine. View Details
- August 2024
- Background Note
Note on Creating Business Plans for Innovative Health Care Ventures
By: Regina E. Herzlinger, Ben Creo, Lee Kaplan and Brian L. Walker
- March 2021 (Revised January 2022)
- Case
Philips: Redefining Telehealth
By: Regina E. Herzlinger, Alec Petersen, Natalie Kindred and Sara M. McKinley
As one of the world’s largest healthcare companies, Philips sought to reach beyond the walls of the hospital and expand its hospital-to-home program to gain future competitive advantage through technology solutions combining predictive analytics with care delivery. By... View Details
Keywords: Health Care; Philips; Visicu; Telemedicine; eICU; Accountable Care Organization; ACO; Bundled Payment; Hospital To Home; Patient Monitoring Devices; Home Health Care; Health Care and Treatment; Communication Technology; Quality; Safety; Performance Productivity; Performance Capacity; Performance Efficiency; Consumer Behavior; Emerging Markets; Health Industry; Telecommunications Industry; Netherlands
Herzlinger, Regina E., Alec Petersen, Natalie Kindred, and Sara M. McKinley. "Philips: Redefining Telehealth." Harvard Business School Case 321-135, March 2021. (Revised January 2022.) (As companion reading for this case, see: Regina E. Herzlinger and Charles Huang. "Note on Bundled Payment in Health Care," HBS Background Note 312-032.)
- August 2003 (Revised August 2006)
- Case
I've Got Rhythm: Selling Cardiac Rhythm Management Devices
By: Regina E. Herzlinger, William Lagor, Christopher Perry and Scott St. Germain
The head of sales and marketing in a large medical devices firm must decide how to assign his sales force. He compares selling in the pharma, specialty pharma, and device industries and analyzes the reasons for the differences. View Details
Keywords: Health Care and Treatment; Marketing Strategy; Industry Structures; Sales; Salesforce Management; Medical Devices and Supplies Industry
Herzlinger, Regina E., William Lagor, Christopher Perry, and Scott St. Germain. "I've Got Rhythm: Selling Cardiac Rhythm Management Devices." Harvard Business School Case 304-012, August 2003. (Revised August 2006.)
- February 2023
- Article
Maintaining Health Care Innovations After the Pandemic
By: Regina E. Herzlinger, Barak D. Richman and Kevin A. Schulman
The COVID-19 pandemic exposed the worst failings of the health care system, but it also stimulated a flurry of innovations that could lead to a much-improved delivery system. These were innovations that were born out of necessity: telemedicine access and use... View Details
Keywords: Health Care; Health Care Industry; Health Care Outcomes; Innovation; Innovation In Healthcare Delivery; COVID; COVID-19 Pandemic; Pandemics; Telemedicine; Telehealth; Ambulatory Care; Vaccines; Innovation and Invention; Change; Health Industry
Herzlinger, Regina E., Barak D. Richman, and Kevin A. Schulman. "Maintaining Health Care Innovations After the Pandemic." e225404. JAMA Health Forum 4, no. 2 (February 2023).
- September 2013 (Revised May 2014)
- Case
OdontoPrev
By: Regina E. Herzlinger, Matthew Lingenbrink, Joshua Turnbull and Ricardo Reisen De Pinho
Brazil's largest dental insurer, a successful and innovative firm, has saturated the corporate market and faces stiffer competition. It must decide whether to enter a new market in Brazil or to expand into other parts of Central and South America. View Details
Keywords: Health; Business or Company Management; Market Entry and Exit; Insurance; Insurance Industry; Health Industry; North and Central America; Brazil
Herzlinger, Regina E., Matthew Lingenbrink, Joshua Turnbull, and Ricardo Reisen De Pinho. "OdontoPrev." Harvard Business School Case 314-038, September 2013. (Revised May 2014.)
- 30 May 2007
- Research & Ideas
Health Care Under a Research Microscope
game is supposed to be quality up and cost down. And this is one where that has not happened. And it's been very slow with the quality movement." Professor Regina Herzlinger, who has studied the health... View Details
- February 1985 (Revised January 2024)
- Case
Health Stop (A): What Type of Innovation Is It? And Six Factors Alignment
By: Regina E. Herzlinger, Joyce Lallman, Nancy Kane, Jefferson C. Grahling and James Wallace
How can we evaluate if innovative health care ventures can do good—benefit society—and do well—become financially viable? This question is the topic of the first module in the Innovating In Health Care course book.
This note and case series enables readers to conduct... View Details
Keywords: For-Profit Firms; Business Model; Entrepreneurship; Health Care and Treatment; Strategy; Valuation; Health Industry; Retail Industry
Herzlinger, Regina E., Joyce Lallman, Nancy Kane, Jefferson C. Grahling, and James Wallace. "Health Stop (A): What Type of Innovation Is It? And Six Factors Alignment." Harvard Business School Case 185-084, February 1985. (Revised January 2024.)
- April 2009 (Revised April 2009)
- Case
Immusol and Novartis
By: Regina E. Herzlinger, Keyne M. Monson, Juan D. Betancourt and Victor Li
Should Immusol strive to become a fully integrated pharmaceutical company? How should a small pharmaceutical company structure a deal for its novel technology with the giant Novartis? View Details
Keywords: Technological Innovation; Rights; Negotiation Deal; Negotiation Participants; Alliances; Pharmaceutical Industry
Herzlinger, Regina E., Keyne M. Monson, and Juan D. Betancourt. "Immusol and Novartis." Harvard Business School Case 303-038, April 2009. (Revised from original October 2002 version.)